EvolveImmune Therapeutics has appointed Jay S. Fine, Ph.D., as the company’s President of Research and Development.
Dr. Fine is an accomplished biopharmaceutical executive with a successful track record of pioneering the discovery and development of first-in-class therapeutics in immunology, inflammatory diseases and tissue fibrosis.